Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reverse Hybrid vs Bismuth Quadruple Therapy for H. pylori Eradication
NCT02547038Completed
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Feb 2015
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pantoprazole, amoxicillin, clarithromycin and metronidazole in Helicobacter pylori infection (2 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoint: Number of Participants in Which H. Pylori Was Eradicated. Started Feb 2015; status: completed.
02
Drugs
pantoprazoleamoxicillinclarithromycinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02547038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02547038.